Pharmacist Provided Spirometry Services: A Scoping Review
Open Access
- 1 August 2021
- journal article
- review article
- Published by Taylor & Francis in Integrated Pharmacy Research and Practice
- Vol. ume 10, 93-111
Abstract
Purpose: Despite international guidelines’ recommendations, spirometry is underutilized in the diagnosis and management of asthma and COPD. Spirometry may be an opportunity for trained pharmacists to meet the needs of patients with suspected or diagnosed lung conditions. The aim of this scoping review is to describe the literature including pharmacist provided spirometry services, specifically to identify: 1) the models of pharmacist provided spirometry services, and additional services commonly offered alongside spirometry, 2) pharmacist training and capability to obtain quality results, and (3) pharmacist, physician, and patient perspectives. Methods: In September 2020, a comprehensive literature search in PubMed and EMBASE was conducted to identify all relevant literature on the topic of pharmacist provided spirometry services using the search term: “pharmacist or pharmacy” and “spirometry or pulmonary function test or lung function test.” Literature was screened using inclusion/exclusion criteria and selected articles were charted and analyzed using the themes above. Results: A total of 27 records were included. The scoping review found that pharmacist provided spirometry has been conducted around the world in community pharmacies and clinic settings. Community pharmacists may increase access to spirometry screening; the lack of communication with primary care providers and remuneration are barriers that need to be overcome to optimize the utility of the service. Clinic-based services are interprofessional and collaborative, allowing a patient to receive the test, results, diagnosis, and medication changes in one visit. Following comprehensive training, pharmacists felt confident in their ability to perform spirometry and met quality standards at acceptable rates. Conclusion: Spirometry is an opportunity for pharmacists to improve evidence-based practice for screening and diagnosing lung conditions along with providing comprehensive services to complement testing. Data around provider and patient perspectives is limited and should be further investigated to determine if providers and patients would value and collaborate with pharmacists providing spirometry services.Keywords
This publication has 49 references indexed in Scilit:
- Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD)International Journal of Chronic Obstructive Pulmonary Disease, 2013
- Feasibility and Effectiveness of an Evidence-Based Asthma Service in Australian Community Pharmacies: A Pragmatic Cluster Randomized TrialJournal of Asthma, 2012
- Experiences of community pharmacists involved in the delivery of a specialist asthma service in AustraliaBMC Health Services Research, 2012
- Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians officePharmacy Practice, 2011
- HERMES Spirometry: the European Spirometry Driving LicenceBreathe, 2011
- Spirometry Use Among Pediatric Primary Care PhysiciansPediatrics, 2010
- Management of chronic obstructive pulmonary disease by pharmacists in an internal medicine departmentAmerican Journal of Health-System Pharmacy, 2009
- Systems for the management of respiratory disease in primary care - an international series: AustraliaPrimary Care Respiratory Journal, 2008
- Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the communityThorax, 2007
- Respiratory function testing: The impact of respiratory scientists on the training and support of primary health care providersRespirology, 2004